Page 36 - நாஸ்டாக் உலகளாவிய தேர்ந்தெடுக்கவும் சந்தை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Nuvalent Announces Pricing of Initial Public Offering News provided by Share this article Share this article CAMBRIDGE, Mass., July 28, 2021 /PRNewswire/  Nuvalent, Inc., a biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced the pricing of its initial public offering of 9,750,000 shares of common stock, consisting of 9,150,000 shares of Class A common stock and 600,000 shares of Class B common stock, each at a price to the public of $17.00 per share. All shares are being offered by Nuvalent. The gross proceeds to Nuvalent from the offering, before deducting underwriting discounts, commissions and other offering expenses, are expected to be approximately $165.75 million. The Class A common stock is expected to begin trading on The Nasdaq Global Select Market under the ticker symbol NUVL on July 29, 2021. The offering is expected to close on August 2, 2021, subject to the satisfaction of cust

United kingdomPiper sandlerProspectus departmentBroadridge financial solutionsNuvalent incExchange commission onJp morgan securitiesPiper sandler coNasdaq global select marketExchange commissionIsland avenueஒன்றுபட்டது கிஂக்டம்பைபர் சாண்ட்லர்ப்ரோஸ்பெக்டஸ் துறைபிராட்ரிட்ஜ் நிதி தீர்வுகள்பரிமாற்றம் தரகு ஆன்